Is MRD eradication a desirable goal in CLL?
Moreno, Carol, MD, Ritgen, Matthias, MD, Rawstron, Andy, PhD
Published in Best practice & research. Clinical haematology (01.03.2010)
Published in Best practice & research. Clinical haematology (01.03.2010)
Get full text
Journal Article
Adherence To The Ibrutinib 420 mg Dose Administered To Patients With Previously Treated CLL
Burger, Jan A., MD, PhD, Barr, Paul M., MD, Brown, Jennifer R., MD, PhD, Hillmen, Peter, MB ChB, PhD, O'Brien, Susan, MD, Barrientos, Jacqueline C., MD, Reddy, Nishitha M., MBBS, MScl, Coutre, Steven, MD, Mulligan, Stephen P., MBBS, MD, FRACP, FRCPA, Jaeger, Ulrich, MD, Furman, Richard R., MD, Cymbalista, Florence, MD, Montillo, Marco, MD, Dearden, Claire, MD, Robak, Tadeusz, MD, PhD, Carol Moreno, MD, Pagel, John, MD, PhD, Suzuki, Samuel, MS, MBA, Sukbuntherng, Juthamas, PhD, Cole, George, MD, James, Danelle F., MD, MAS, Byrd, John C., MD
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article